Application Information

This drug has been submitted to the FDA under the reference 022369/001.

Names and composition

"LATISSE" is the commercial name of a drug composed of BIMATOPROST.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022369/001 LATISSE BIMATOPROST SOLUTION/DROPS/TOPICAL 0.03%

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021275/001 LUMIGAN BIMATOPROST SOLUTION/DROPS/OPHTHALMIC 0.03% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
022184/001 LUMIGAN BIMATOPROST SOLUTION/DROPS/OPHTHALMIC 0.01%
022369/001 LATISSE BIMATOPROST SOLUTION/DROPS/TOPICAL 0.03%
090449/001 BIMATOPROST BIMATOPROST SOLUTION/DROPS/OPHTHALMIC 0.03%
200487/001 BIMATOPROST BIMATOPROST SOLUTION/ OPHTHALMIC 0.03
201894/001 BIMATOPROST BIMATOPROST SOLUTION/DROPS/TOPICAL 0.03%
202565/001 BIMATOPROST BIMATOPROST SOLUTION/DROPS/OPHTHALMIC 0.03%
202719/001 BIMATOPROST BIMATOPROST SOLUTION/DROPS/TOPICAL 0.03%
203056/001 BIMATOPROST BIMATOPROST SOLUTION/ OPHTHALMIC 0.01%
203404/001 BIMATOPROST BIMATOPROST SOLUTION/OPHTHALMIC 0.01%
203991/001 BIMATOPROST BIMATOPROST SOLUTION/DROPS/OPHTHALMIC 0.03%

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved